Extensive cardiac assessment in cancer patients treated with immune checkpoint inhibitors
Bron
Antwerp, University of Antwerp, Faculty of Medicine and Health Sciences, 2024,206 p.
Close cardiovascular monitoring during the early stages of treatment for patients receiving immune checkpoint inhibitors
Bron
Pharmaceuticals - ISSN 1424-8247-17:7 (2024) p. 1-12
Intermediate molecular phenotypes to identify genetic markers of anthracycline-induced cardiotoxicity risk
Bron
Cells - ISSN 2073-4409-12:15 (2023) p. 1-28
Extensive CArdioVAscular characterization and follow-up of patients receiving immune checkpoint inhibitors : a prospective multicenter study
Bron
Pharmaceuticals - ISSN 1424-8247-16:4 (2023) p. 1-14
First evidence of activity of enfortumab vedotin on brain metastases in urothelial cancer patients
Bron
Pharmaceuticals - ISSN 1424-8247-16:3 (2023) p. 1-8